Founded in 1946 and headquartered in Halberstadt, Germany, Primed designs, manufactures and distributes certified single-use medical consumables. The business employs more than 450 people across a vertically integrated platform spanning the full value chain, from compounding to final sterile product. Its MDR-certified products are used in over 70 countries, supplying hospitals and medical care facilities. Primed also operates HA2, one of Europe's largest medical sterilisation platforms.

Martin Siml, Managing Director at Barings Global Private Finance Group, said: “We are delighted to back Inflexion's acquisition of Primed, a prominent transaction in the Medtech sector in the DACH region. We look forward to working alongside Inflexion and management as they continue to expand the business.”

About Barings
Barings is a $502 billion* global alternative asset manager that partners with institutional, insurance and wealth clients and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual with a minority investment from MS&AD, seeks to deliver excess returns by leveraging its global scale and capabilities across credit, real assets, capital solutions and emerging markets.

*As of June 30, 2026

About Inflexion
Inflexion is a leading European middle-market private equity firm with €20 billion under management, investing in high-growth, entrepreneurial businesses with ambitious management teams and working in partnership with them to accelerate growth. Inflexion’s flexible approach allows it to make both majority and minority investments in businesses typically valued from €50 million to more than €1 billion. With bespoke teams and dedicated capital, Inflexion’s funds invest across six key sectors from offices in London, Manchester, Amsterdam, Frankfurt, Stockholm, and New York. https://www.inflexion.com/

26-5908287